Effect of interplay between age and low-flow duration on neurologic outcomes of extracorporeal cardiopulmonary resuscitation.

PURPOSE: Caseloads of extracorporeal cardiopulmonary resuscitation (ECPR) have increased considerably, and hospital mortality rates remain high and unpredictable. The present study evaluated the effects of the interplay between age and prolonged low-flow duration (LFD) on hospital survival rates in elderly patients to identify subgroups that can benefit from ECPR.
METHODS: Adult patients who received ECPR in our institution (2006-2016) were classified into groups 1, 2, and 3 (18-65, 65-75, and > 75 years, respectively). Data regarding ECPR and adverse events during hospitalization were collected prospectively. The primary end point was favorable neurologic outcome (cerebral performance category 1 or 2) at hospital discharge.
RESULTS: In total, 482 patients were divided into groups 1, 2, and 3 (70.5%, 19.3%, and 10.2%, respectively). LFDs were comparable among the groups (40.3, 41.0, and 44.3 min in groups 1, 2, and 3, P = 0.781, 0.231, and 0.382, respectively). Favorable neurologic outcome rates were nonsignificantly lower in group 3 than in the other groups (27.6%, 24.7%, and 18.4% for group 1, 2, and 3, respectively). Subgroup analysis revealed that the favorable neurologic outcome rates in group 1 were 36.7%, 25.4%, and 13.0% for LFDs of < 30, 30-60, and > 60 min, respectively (P = 0.005); in group 2, they were 32.1%, 21.2%, and 23.1%, respectively (P = 0.548); in group 3 they were 25.0%, 20.8%, and 0.0%, respectively (P = 0.274).
CONCLUSION: On emergency consultation for ECPR, age and low-flow duration should be considered together to predict neurologic outcome.

Introduction

Extracorporeal cardiopulmonary resuscitation (ECPR) is labor-intensive work, and the caseload has increased considerably in the past decade, accounting for one-quarter of adult extracorporeal membrane oxygenation (ECMO) cases of cardiac support [1]. ECPR is an expensive and labor-intensive mode of circulatory support, but the overall hospital survival rate for adult ECPR cases is relatively low at 29% [1]. Thus, more than two-thirds of ECPR efforts are futile in terms of hospital survival. From the viewpoint of balance of beneficence and nonmaleficence versus autonomy, dignity for elderly patients undergoing cardiopulmonary resuscitation (CPR) [2], and limited resources and overloaded manpower in emergency ECMO services, predicting the outcome of ECMO during CPR by considering prominent risk factors is practical and mandatory. A do-not-resuscitate (DNR) order can be obtained for patients who are unlikely to benefit from ECMO support.

Age and low-flow duration (LFD) are two of the most prominent factors affecting ECPR. Several studies have shown that prolonged LFDs are significantly associated with poor hospital outcomes for ECPR [3, 4], with an approximate survival rate of only 10–17% if LFDs exceed 60 min. Animal experiments have indicated that old and young animals present different degrees of neuroinflammation and apoptosis reaction after brain ischemic damage [5, 6]. The number of elderly patients being referred for ECMO support when undergoing CPR has increased in recent years [7-10]. Although “age” has not been indicated to have a negative linear correlation with hospital survival in patients with ECPR [7, 11], the Good Outcome Following Attempted Resuscitation score [12] for CPR and the survival after veno-arterial-ECMO (SAVE) score [13] for ECMO both indicate that old age is a risk factor for poor hospital outcomes. The present study evaluated whether advanced old age (> 75 years) is a contraindication for ECPR regarding hospital outcome, with a particular focus on the effect of interplay between old age and prolonged LFDs. The results can enable the identification of subgroups among elderly patients that can benefit from ECPR. Our study results may provide objective data for deciding between ECMO and DNR and for ensuring efficient utilization of medical resources.

Methods

Our hospital is a tertiary referral hospital located in an urban area with 20 years of experience in ECMO [14, 15] and 12 years of experience in ECPR [3, 16, 17]. An ECPR task force was established in our institute in 2003 [3, 18]. The institutional review board of our hospital approved this study (NTUH-9561707007). All data were prospectively collected and systemically reviewed, and several results have been reported in previous studies [17, 19, 20]. In the present study, we analyzed the data of all adult patients (age ≥ 18 years) who had received ECPR at our institution between 2006 and 2016 by using a database. The patients whose index ECPR was not performed in our hospital were excluded because of unstandardized definitions of the arrest time, CPR duration, and ECMO management protocol. The patients who experienced shock necessitating ECMO in an elective or emergency situation without cardiac massage or multiple boluses of epinephrine injection were also excluded, as were those with incomplete CPR data, follow-up data, and cerebral performance category (CPC) data after hospital discharge. The patients who experienced shock necessitating CPR for < 10 min were excluded because they did not meet the criterion of “prolonged” CPR. The contraindications of ECPR were adapted from the previously reported contraindications [3, 20] and are listed in Supplementary Table 1. The equipment and management of ECMO have been described in previous studies [3, 18, 20]. The principal components of the ECMO circuit used on our patients were centrifugal pumps and an oxygenator (Medtronic, Anaheim, CA, USA; Medos, Stolberg, Germany; Maquet, Rastatt, Germany). The circuit was preorganized without priming and was then primed using saline containing 2 U/ml heparin when an ECPR call was received.

Out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) were defined as any cardiac arrest event outside and inside the hospital, respectively. For the patients who experienced OHCA, CPR and attempted defibrillation were initiated by well-trained emergency medical technicians (EMTs) in compliance with the guidelines of the American Heart Association [21]. CPR was continuously performed on the patients while they were being transported to our institution. Physicians in the emergency room consulted the ECMO team to decide whether the patient was eligible for ECPR (10 min) after advanced cardiac life support (ACLS) management. The patients who experienced IHCA were provided with onsite ACLS, or advanced life support was provided immediately by the neighboring medical personnel. An on-call CPR team responded rapidly after receiving an emergency call. After 10 min of initial ACLS management, which included several instances of cardiac defibrillation and bolus injection of epinephrine, the medical personnel in charge consulted the ECMO team to decide whether the patient was eligible for ECPR. LFD was defined as the interval between initiation of CPR and initiation of ECMO support.

The patients’ demographic and health data before index CPR were collected immediately after ECMO setup. The Charlson Comorbidity Index (CCI) score before the index CPR was calculated using a formula containing 17 variables [22, 23]. Data regarding major outcomes and adverse events during hospitalization were collected during hospitalization. The major outcome was a favorable neurologic outcome (CPC 1 or 2) at hospital discharge. The follow-up data of the patients who survived ECPR until hospital discharge were collected through chart review and telephone interviews.

Statistical analysis

The patients were grouped according to their ages at index ECPR into three groups, namely group 1 (18–65 years), group 2 (65–75 years), and group 3 (> 75 years). Continuous variables that exhibited a normal distribution were presented as the mean ± standard deviation and were examined using Student’s t test. Continuous variables that exhibited a skewed distribution were presented as the median and 25–75% interquartile range and were examined using the Mann-Whitney U test or Wilcoxon test. Categorical variables were analyzed using the chi-square test. The variables affecting the major outcome (i.e., hospital survival) that were significant (P < 0.15) in univariate analysis were included in multivariate logistic regression with backward stepwise analysis. Midterm survival was modeled using the Kaplan-Meier method, and the log-rank test was applied to test statistical significance. Statistical significance was set at P < 0.05. All statistical analyses were performed using MedCalc statistical software version 17.8.6 (MedCalc Software, Ostend, Belgium).

Results

In total, 5664 patients experienced cardiac arrest and received CPR in our institution between 2006 and 2016 (IHCA and OHCA, 3376 and 2288 patients, respectively). Among them, 502 patients received ECMO support (ECPR cases); 20 of these patients were excluded from the present study because of incomplete data, and the remaining 482 were included (Fig. 1). The patients in groups 1, 2, and 3 accounted for 70.5%, 19.3%, and 10.2% of all the study patients, respectively. Although the number of cases of ECPR increased in consecutive years in the study period, the proportions of the three age groups did not differ significantly between years (Supplement Fig. 1). The demographic data of the three age groups are summarized in Table 1. In brief, group 1 exhibited a significantly lower incidence of diabetes, chronic kidney disease stages 4 and 5, chronic obstructive pulmonary disease, peripheral vascular disease, and age-related stroke than those in groups 2 and 3. The mean CCI score was also lower in group 1 than in groups 2 or 3 (1.34 ± 1.77, 2.14 ± 2.00, and 2.37 ± 1.95 in groups 1, 2, and 3, respectively). All the aforementioned data revealed that the general condition before index CPR events was better in the younger patients than in the older patients.

Fig. 1

Flowchart of study patients

Table 1

Demographic data of patients in different age groups who received extracorporeal cardiopulmonary resuscitation (ECPR)

	Group 1: 18–65 years old (340)	Group 2: 65–75 years old (93)	Group 3: > 75 years old (49)	P
Female gender	71 (20.9%)	27 (29.0%)	16 (32.7%)	0.077
Age (years)	49.4 ± 11.8	69.5 ± 3.0	80.2 ± 3.9	1–2: < 0.0011–3: < 0.0012–3: < 0.001
Diabetes mellitus	106 (31.2%)	44 (47.3%)	26 (53.1%)	1–2: 0.0041–3: 0.0032–3: 0.516
CKD-4, 5	39 (11.5%)	19 (20.4%)	13 (26.5%)	1–2: 0.0251–3: 0.0042–3: 0.410
NYHA-3, 4	77 (22.6%)	25 (26.9%)	15 (30.6%)	1–2: 0.3941–3: 0.2212–3: 0.640
COPD	3 (0.9%)	2 (2.2%)	5 (10.2%)	1–2: 0.3111–3: < 0.0012–3: 0.036
Peripheral vascular disease	12 (3.5%)	9 (9.7%)	6 (12.2%)	1–2: 0.0151–3: 0.0072–3: 0.637
Old CVA or TIA	19 (5.6%)	10 (10.8%)	8 (16.3%)	1–2: 0.0781–3: 0.0062–3: 0.344
Malignancy	15 (4.4%)	8 (8.6%)	3 (6.1%)	1–2: 0.1111–3: 0.5952–3: 0.601
CCI	1.34 ± 1.77	2.14 ± 2.00	2.37 ± 1.95	1–2: < 0.0011–3: < 0.0012–3: 0.517
Main CPR causes
Acute coronary syndrome	118 (34.7%)	47 (50.5%)	25 (51.0%)	1–2: 0.0051–3: 0.0272–3: 0.975
Chronic heart failure	63 (18.5%)	13 (14.0%)	2 (4.1%)	1–2: 0.3071–3: 0.0112–3: 0.069
Septic shock	29 (8.5%)	4 (4.3%)	4 (8.2%)	1–2: 0.1741–3: 0.9322–3: 0.344
Post-cardiotomy	20 (5.9%)	22 (7.5%)	7 (14.3%)	1–2: 0.5621–3: 0.0312–3: 0.201
Others	110 (32.4%)	12 (23.7%)	11 (22.4%)
OHCA	87 (25.6%)	15 (16.1%)	3 (6.1%)	1–2: 0.0571–3: 0.0032–3: 0.090
Low-flow duration (min)	40.3 ± 21.2	41.0 ± 18.6	44.3 ± 26.6	1–2: 0.7811–3: 0.2312–3: 0.382

CKD chronic kidney disease, NYHA New York Heart Association, COPD chronic obstructive pulmonary disease, CVA cerebral vascular attack, TIA transient ischemic attack, ACS acute coronary syndrome, CPR cardiopulmonary resuscitation, ECMO extracorporeal membrane oxygenation, OCHA out-of-hospital cardiac arrest, low-flow duration duration between CPR and ECMO run, CCI Charlson Comorbidity Index

When the underlying causes of CPR were considered, group 1 exhibited a lower percentage of patients with acute coronary syndrome (ACS) than groups 2 and 3 (34.7%, 50.5%, and 51.0% in groups 1, 2, and 3, respectively; P = 0.005 between groups 1 and 2 and P = 0.027 between groups 1 and 3). However, group 3 exhibited a lower percentage of patients with chronic heart failure than did groups 1 and 2 (18.5%, 14.0%, and 4.1% in groups 1, 2, and 3, respectively) (Table 1). The findings suggest that a relatively high percentage of elderly patients with acute illness rather than chronic illness were referred for ECPR. The percentage of OHCA decreased as the age increased in the three groups (25.6%, 16.1%, and 6.1% in groups 1, 2, and 3, respectively), which possibly reflected clinical discretion against ECPR use for the elderly patients who experienced OHCA. The LFDs of the three groups were comparable (40.3 ± 21.2, 41.0 ± 18.6, and 44.3 ± 26.6 min in groups 1, 2, and 3, respectively).

The hospital outcomes for all the study patients are listed in Table 2. In brief, 44.2% of the patients were weaned off ECMO support, and 29.7% survived to hospital discharge. CPC 1, 2, 3, 4, and 5 account for 25.3%, 0.8%, 1.0%, 2.5%, and 70.3%, respectively, with a total of 26.1% exhibiting favorable neurologic outcomes with CPC 1 or 2. Specifically, the ECMO weaning rate was higher in group 1 than in group 3 (47.6%, 39.8%, and 28.6% for groups 1, 2, and 3, respectively; P = 0.012 between groups 1 and 3). The hospital survival rate was higher in group 1 than in group 3 (32.1%, 26.9%, and 18.4% in groups 1, 2, and 3, respectively; P = 0.052 between groups 1 and 3). However, the rates of favorable neurologic outcomes (CPC 1, 2 at discharge) did not differ considerably among the three groups (27.6%, 24.7%, and 18.4% for groups 1, 2, and 3, respectively; P = 0.575, 0.169, and 0.390 between groups 1 and 2, 1 and 3, and 2 and 3, respectively). The average ECMO support duration was lower in group 3 compared with group 1 and 2 (4.3, 3.0, 1, and 7 days for group 1, 2, and 3). After adjusting for their respective ECMO wean-off rate (47.6%, 39.8%, and 28.6% for group 1, 2, and 3), the adjusted ECMO support duration was higher for the younger group (9.0, 7.5, and 5.9 days for group 1, 2, and 3), indicating longer ECMO support for young patients than old patients.

Table 2

Outcome of ECPR

	18–65 years old (340)	65–75 years old (93)	> 75 years old (49)	P
ECMO days	4.3 ± 6.8	3.0 ± 4.0	1.7 ± 1.8	1–2: 0.0861–3: 0.0092–3: 0.033
Ventilator days	12.3 ± 21.4	7.6 ± 11.5	4.0 ± 7.7	1–2: 0.0421–3: 0.0072–3: 0.049
ICU days	14.2 ± 20.9	9.4 ± 13.5	6.6 ± 12.6	1–2: 0.0371–3: 0.0162–3: 0.239
Hospitalization days	24.3 ± 36.3	15.9 ± 25.1	10.3 ± 22.1	1–2: 0.0361–3: 0.0092–3: 0.195
Weaned off ECMO	162 (47.6%)	37 (39.8%)	14 (28.6%)	1–2: 0.1781–3: 0.0122–3: 0.187
Hospital survival at discharge	109 (32.1%)	25 (26.9%)	9 (18.4%)	1–2: 0.3391–3: 0.0522–3: 0.260
Favorable neurologic outcome (CPC 1, 2 at discharge)	94 (27.6%)	23 (24.7%)	9 (18.4%)	1–2: 0.5751–3: 0.1692–3: 0.390

Data are presented by age group

CPC cerebral performance category

The overall 3-year survival rates were lower among the group 3 patients (11.4%) than among the group 1 (25.5%, P < 0.001) or group 2 (24.7%, P = 0.064) patients (Fig. 2). The 3-year survival probabilities of the patients who survive to hospital discharge were all > 60% in the three groups (78.7%, 92.0%, and 64.8% in groups 1, 2, and 3, respectively).

Fig. 2

Kaplan-Meier survival curve for extracorporeal cardiopulmonary resuscitation in different age groups for a all study patients and b hospital survivors

Risk factor analysis for favorable neurologic outcomes with univariate logistic regression analysis revealed that CPR due to sepsis, LFDs, and early year of ECPR were potential risk factors for favorable neurologic outcomes (all with P < 0.15) (Table 3). Notably, age was not a significant factor affecting favorable neurologic outcomes [odds ratio (OR) of 0.96 for every 10-year increment, P = 0.573]. The multivariate logistic regression analysis revealed that only CPR due to sepsis and prolonged LFDs exhibited negative effects on favorable neurologic outcomes (P = 0.013, P < 0.001, respectively), whereas early year of ECPR exhibited negative effects on favorable outcomes (P = 0.086).

Table 3

Logistic regression analysis for hospital discharge with favorable neurologic function (CPC-1, 2)

	Univariate analysis		Multivariate analysis
	OR (95% CI)	P	OR (95% CI)	P
Female gender	0.95 (0.59–1.54)	0.845	–	–
CCI	0.93 (0.98–1.04)	0.205	–	–
Age (+10 years)	0.96 (0.84–1.10)	0.573	–	–
Age > 65 years old	0.76 (0.48–1.21)	0.245	–	–
Age > 75 years old	0.61 (0.29–1.29)	0.195	–	–
CPR due to ACS	1.21 (0.80–1.83)	0.359	–	–
CPR due to sepsis	0.23 (0.07–0.77)	0.017*	0.21 (0.06–0.73)	0.013
CPR due to post-cardiotomy	1.38 (0.65–2.93)	0.394	–	–
Low-flow duration (+ 10 min)	0.80 (0.71–0.90)	< 0.001*	0.79 (0.70–0.89)	< 0.001
OHCA	0.85 (0.51–1.41)	0.539	–	–
ECPR period
Period 1 (2006–2009)	0.69 (0.43–1.10)	0.119*	0.65 (0.39–1.06)	0.086
Period 2 (2010–2013)	1.39 (0.91–2.11)	0.130	–	–
Period 3 (2014–2016)	1.00 (0.66–1.51)	0.983	–	–

Variables with P <  0.15 by univariate analysis (marked with an asterisk) were subjected to multivariate analysis. The multivariate logistic regression analysis was set with entry and removal P values of 0.10 and 0.15, respectively

Because age and LFD were two prominent clinical factors that could be collected immediately at the site of CPR, the patients were divided into subgroups according to age and LFD to evaluate the effect of the interaction between age and LFD on favorable neurologic outcomes (Fig. 3). The favorable neurologic outcome rates were 34.6%, 24.1%, and 13.2% among the patients with LFDs of < 30, 30–60, and > 60 min, respectively (P = 0.002.) As shown in Fig. 3, group 1 had a mean LFD of < 30 min and was associated with the highest neurologic outcome rate (36.7%), whereas group 3 had a mean LFD of  > 60 min and was associated with the lowest neurologic outcome rate (0.0%). Notably, the rate of favorable neurologic outcomes in group 3 with a mean LFD of < 30 min (25.0%) was similar to the rate in group 1 with a mean LFD of  > 60 min (13.0%) (P = 0.249), thus indicating that under the current cardiopulmonary resuscitation protocol and ECPR selection criteria, patients aged > 75 years still have a 25% chance of surviving the indexed cardiac arrest episode.

Fig. 3

Effects of interplay between age and low-flow duration on favorable neurologic outcome rates after extracorporeal cardiopulmonary resuscitation

To elucidate whether the patients who experienced IHCA and OHCA had different neurologic outcomes depending on their ages or LFDs, the results of subgroup analysis are shown in Supplement Fig. 2. The results revealed that under the current selection criteria for ECMO use (Supplement Table 1), the rate of favorable neurologic outcomes in the patients who experienced OHCA was almost equal to that in the patients who experienced IHCA in each subgroup of age and LFD.

Discussion

Age and LFD are the two most determinative factors in the emergency scenario of CPR. Studies have shown that both advanced age and prolonged LFDs are associated with poor neurologic outcomes [3, 4, 13]; therefore, both are generally considered contraindications for ECMO use in CPR [24]. However, whether relatively young patients with long LFDs or elderly patients with relatively short LFDs have acceptable chances of survival after ECPR has not been studied. This article reports real-world data regarding the effects of interplay between age and LFD on favorable neurologic outcome rates after ECPR. The results revealed that for LFDs of < 60 min, ECPR was associated with an acceptable hospital outcome regardless of age, whereas for LFDs of  > 60 min, ECPR was associated with poor neurologic outcomes only for the patients aged > 75 years. These findings provide objective references for shared decisions regarding the use of ECPR in elderly patients or patients with prolonged cardiac massage durations.

The results of the present study revealed that for elderly patients with LFDs of < 60 min, the neurologic outcomes of ECPR were not as poor as previously thought; this finding was inconsistent with the Extracorporeal Life Support Organization (ELSO) guidelines, which define advanced age as an absolute or relative contraindication for ECPR [24]. Previous studies have indicated that intrinsically old age is not a risk factor for hospital mortality after ECPR of either IHCA [25] or OHCA [9, 26]. By contrast, the underlying cause of cardiac collapse affects hospital survival more than age does. As shown in Table 1, the proportion of patients with ACS as the etiology of cardiac arrest was higher in the elderly ECPR patients than in the younger patients, whereas the proportion of patients with chronic heart failure as the etiology of cardiac arrest was higher in the younger patients than in the elderly ECPR patients. Because of the rapid door-to-balloon protocol currently practiced, ECMO use for ACS has been reported to be associated with acceptable outcomes [27-29], if treated promptly. By contrast, ECPR due to septic shock, which is usually associated with a complex underlying comorbidity, was associated with a relatively low rate of favorable outcomes, as reported in the present study and in a previous study [30]. The proportion of patients with sepsis as the etiology of cardiac arrest in this study was lower in the elderly patients (4.3% and 8.2% in groups 2 and 3, respectively) than in the younger patients (8.5% in group 1).

Traditional CPR for patients who experienced OHCA and IHCA was associated with low hospital survival rates, namely 7.2–9.9% [10, 31, 32] and 14.2–15.7% [33, 34], respectively. Notably, most of the patients achieving return of spontaneous circulation (ROSC) were resuscitated for < 30 min (42.5%), whereas only 6% of patients achieving ROSC were resuscitated for > 30 min [33].

The ECPR program was specifically designed for patients who receive sustained CPR for > 30 min and for improving their chances of hospital survival [3, 18, 20]. Hospital survival rate has been found to improve slightly from 29.0 to 29.7% after ECPR [1, 20]. In addition, studies have compared the efficacy of ECPR with conventional CPR in preventing long-term neurologic damage and have shown that ECPR provides markedly better neurologic protection than does traditional CPR [35]. However, ECMO per se is also associated with the risks of neurologic injury [36, 37], including anoxic brain injury, intracranial hemorrhage, and ischemic stroke. Old age, prior CPR, and low arterial pressure during ECMO support are associated with poor neurologic outcomes [36] and hospital mortality [13].

Animal studies have also demonstrated that responses to neurologic injuries after ischemia are different in young and old animals [6]; young and old animals exhibit relatively high levels of hypoxic and apoptotic injury, respectively. A previous study [38] on the pathologic examination of patients with cardiac arrest revealed that the severity of hypoxic ischemic brain injury is correlated with prolonged survival time after cardiac arrest instead of age, hypertension, or diabetes. These findings indicate that after cardiac arrest, hypoxic brain injury is a complicated and reactive process, which involves an interaction among initial hypoxic damage, reperfusion injury, subsequent oxidative reactions, and apoptotic reactions [39, 40]. New strategies to prevent or alleviate neurologic injury after ECPR, including pharmacologic vasodilation [41], post-ECPR conditioning [39, 42], or systemic [43, 44] or intracranial therapeutic hypothermia [45], are potential innovative treatments to improve neurologic outcomes after ECPR.

Elderly patients aged > 65 years accounted for 29.4% of all ECPR cases in the present study, which was similar to ELSO registry data [11], but the percentage was considerably lower than the traditional CPR registry data of 60–70% [10, 32, 34]. This indicates that clinical discretion during CPR consultation favors young patients for ECMO support. In addition to age, patients with low CCI scores (J Clin Med 7(10):313; https://doi.org/10.3390/jcm7100313 (2018) (registering DOI) ) who had received short-duration cardiac massages, high-quality CPR from EMTs [31], or ACS in etiology (according to initial assessments) had relatively high chances of receiving ECMO during CPR as a temporary cardiopulmonary support for the definite diagnosis and treatment and later recovery of cardiopulmonary and neurologic functions.

As shown in Fig. 2, the 3-year survival probabilities were 79%, 92%, and 65% in groups 1, 2, and 3, respectively. Late mortality in CPR patients after hospital discharge has emerged as a new problem. Get With The Guidelines-Resuscitation registry data revealed that only 60% of IHCA survivors survived at 1 year [46]. Continuous morbidity and mortality may be attributed to a relatively high frequency of posttraumatic stress disorder, low levels of well-being [47] and cognitive function, and impaired activities of daily living [48] in OHCA survivors. These findings indicate that a post-ECPR specialized joint care program is necessary for ECPR survivors.

Limitations

First, the number of study patients was low, which may have affected the data analysis. Second, the present study was not a prospective randomized study and performed in a single institute, and there may have been selection bias in both the young and old patients for ECMO use that favored patients who had fewer pre-existing comorbidities, shorter period of cardiac collapse time, or received better quality of CPR. Finally, the outcome of ECPR was determined by a combination of ECMO and pre-ECMO conditions, including extensiveness and endurance of CPR. Khan et al. [49] reported that the duration of CPR for non-ROSC patients was lower in patients aged > 65 years and with pre-existing comorbidities.

Clinical implications

Considering hospital survival and neurologic outcome rates, ECPR is a suitable treatment for either elderly patients with short cardiac arrest durations or young patients with long cardiac arrest durations. However, ECPR is not recommended for use in elderly patients with prolonged cardiac arrest duration owing to the relatively poor associated outcomes.

Below is the link to the electronic supplementary material.

Supplement Fig.1: Extracorporeal cardiopulmonary resuscitation case numbers by year and age.Legend: P = 0.961 using the chi-square test(TIFF 3169 kb )

Supplement Fig.2: Favorable neurologic outcome (CPC 1, 2) grouped by OHCA and IHCA (TIFF 6509 kb)

Supplement material 3 (DOC 34 kb)